Literature DB >> 21741404

Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins.

Hua She1, Zixu Mao.   

Abstract

Various isoforms of myocyte enhancer factor-2 (MEF2) constitute a group of nuclear proteins found to play important roles in increasing types of cells. In neurons, MEF2s are required to regulate neuronal development, synaptic plasticity, as well as survival. MEF2s promote the survival of several types of neurons under different conditions. In cellular models, negative regulation of MEF2s by stress and toxic signals contributes to neuronal death. In contrast, enhancing MEF2 activity not only protects cultured primary neurons from death in vitro but also attenuates the loss of dopaminergic neurons in substantia nigra pars compacta in a 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. In this work, the mechanisms of regulation of MEF2 function by several well-known neurotoxins and their implications in various neurodegenerative diseases are reviewed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741404      PMCID: PMC3200477          DOI: 10.1016/j.neuro.2011.05.019

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  35 in total

Review 1.  MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation.

Authors:  F J Naya; E Olson
Journal:  Curr Opin Cell Biol       Date:  1999-12       Impact factor: 8.382

2.  Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway.

Authors:  Teralee R Burton; Alex Dibrov; Tarek Kashour; Francis M Amara
Journal:  Brain Res Mol Brain Res       Date:  2002-12

3.  Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.

Authors:  Shu-ichi Okamoto; Zhen Li; Chung Ju; Marion N Scholzke; Emily Mathews; Jiankun Cui; Guy S Salvesen; Ella Bossy-Wetzel; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 4.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

Authors:  D Blum; S Torch; N Lambeng; M Nissou; A L Benabid; R Sadoul; J M Verna
Journal:  Prog Neurobiol       Date:  2001-10       Impact factor: 11.685

5.  MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.

Authors:  S M Kolodziejczyk; L Wang; K Balazsi; Y DeRepentigny; R Kothary; L A Megeney
Journal:  Curr Biol       Date:  1999-10-21       Impact factor: 10.834

6.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2.

Authors:  Z Mao; A Bonni; F Xia; M Nadal-Vicens; M E Greenberg
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

Review 7.  MEF2: a calcium-dependent regulator of cell division, differentiation and death.

Authors:  Timothy A McKinsey; Chun Li Zhang; Eric N Olson
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

8.  Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons.

Authors:  M Li; D A Linseman; M P Allen; M K Meintzer; X Wang; T Laessig; M E Wierman; K A Heidenreich
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

9.  Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.

Authors:  H D Youn; T A Chatila; J O Liu
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

10.  Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro.

Authors:  N Crespo-Biel; A Camins; M Pallàs; A M Canudas
Journal:  Neuropharmacology       Date:  2008-10-07       Impact factor: 5.250

View more
  10 in total

Review 1.  Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Janghoo Lim
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

2.  Neurotoxin-induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response.

Authors:  Hua She; Qian Yang; Zixu Mao
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

Review 3.  Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.

Authors:  Ronglin Wang; Shaosong Yang; Tiejian Nie; Gang Zhu; Dayun Feng; Qian Yang
Journal:  Neurosci Bull       Date:  2017-08-08       Impact factor: 5.203

4.  Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.

Authors:  D M Vargas; M A De Bastiani; R B Parsons; F Klamt
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

5.  Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization.

Authors:  Li Zhang; Yang Sun; Mingjian Fei; Cheng Tan; Jing Wu; Jie Zheng; Jiqing Tang; Wei Sun; Zhaoliang Lv; Jiandong Bao; Qiang Xu; Huixin Yu
Journal:  Autophagy       Date:  2014-06       Impact factor: 16.016

6.  Effects of new polymorphisms in the bovine myocyte enhancer factor 2D (MEF2D) gene on the expression rates of the longissimus dorsi muscle.

Authors:  E Juszczuk-Kubiak; R R Starzyński; T Sakowski; K Wicińska; K Flisikowski
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

7.  PSMA6 (rs2277460, rs1048990), PSMC6 (rs2295826, rs2295827) and PSMA3 (rs2348071) genetic diversity in Latvians, Lithuanians and Taiwanese.

Authors:  Tatjana Sjakste; Natalia Paramonova; Lawrence Shi-Shin Wu; Zivile Zemeckiene; Brigita Sitkauskiene; Raimundas Sakalauskas; Jiu-Yao Wang; Nikolajs Sjakste
Journal:  Meta Gene       Date:  2014-04-17

Review 8.  Oxidative RNA Damage in the Pathogenesis and Treatment of Type 2 Diabetes.

Authors:  Xiatian Chen; Hua Yu; Zhe Li; Wei Ye; Ziqian Liu; Jinning Gao; Yin Wang; Xin Li; Lei Zhang; Natalia Alenina; Michael Bader; Hongyan Ding; Peifeng Li; Lynn Htet Htet Aung
Journal:  Front Physiol       Date:  2022-03-28       Impact factor: 4.566

Review 9.  Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities.

Authors:  Yi-Ting Wang; Jia-Hong Lu
Journal:  Cells       Date:  2022-07-20       Impact factor: 7.666

10.  NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases.

Authors:  Dokyun Na; Mushfiqur Rouf; Cahir J O'Kane; David C Rubinsztein; Jörg Gsponer
Journal:  BMC Med Genomics       Date:  2013-11-14       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.